CEO.COM

CEO.com Video Library

NOW PLAYING
Juno, Celgene’s $1B Cancer-Fighting Deal: CEO
CNBC - July 1, 2015 - Duration: 3:28

Hans Bishop, Juno Therapeutics CEO, discusses the company's strategic collaboration with Celgene to develop advance immunotherapies for patients with cancer and autoimmune diseases.